In vivo studies in mice have shown the Rho GEFs P-Rex2, Vav2, Vav3 and PDZ-RhoGEF to be involved in glucose tolerance and/or insulin sensitivity, with deletion of these GEFs either contributing to the development of metabolic syndrome or protecting mice from this disease. Here, PREX2 is linked to metabolic syndrome.